- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Anagliptin
Total 390 results
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Czech Republic, Finland, Greece, India, Israel, Mexico, New Zealand, Russian Federation, Sweden
-
Korea University Anam HospitalCompletedDiabetes MellitusKorea, Republic of
-
AstraZenecaCompletedType 2 Diabetes Mellitus, CKD and AlbuminuriaUnited States, Spain, Canada, Korea, Republic of, Mexico, Japan, Taiwan, Australia, South Africa
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Argentina, Belgium, Canada, China, Germany, Korea, Republic of, Philippines, Russian Federation, Taiwan, Turkey, United Kingdom
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Croatia, India, Israel, Italy, Malaysia, Netherlands, Poland, Romania, Slovakia, Thailand, Ukraine
-
Seoul National University HospitalUnknownType 2 Diabetes Mellitus
-
TakedaCompleted
-
AstraZenecaParexelCompletedType 2 Diabetes MellitusUnited States
-
Emory UniversityBoston Medical Center; Rush University; University of DenverCompleted
-
AstraZenecaCompletedType 2 Diabetes MellitusBrazil
-
Beni-Suef UniversityCompleted
-
Kyowa Kirin Co., Ltd.Completed
-
BiogenCompletedAcute Ischemic StrokeSpain, United States, Germany
-
Fayoum UniversityBoehringer IngelheimCompletedDiabetes | Microalbuminuria | Kidney Function Affection Upon Exposure to RadiocontrastEgypt
-
Shanghai Zhongshan HospitalChinese Medical AssociationCompleted
-
Long Min,MDUnknownDiabetic Foot UlcerChina
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Germany, Spain, United States, Canada, Taiwan, Korea, Republic of, Finland, Denmark, France, Japan, Philippines, Vietnam
-
Fourth People's Hospital of ShenyangCompleted
-
Boehringer IngelheimCompleted
-
BiogenTerminated
-
JW PharmaceuticalActive, not recruitingType 2 Diabetes MellitusKorea, Republic of
-
TakedaCompletedType 2 Diabetes MellitusKorea, Republic of
-
Rabin Medical CenterTerminatedGlucose Metabolism Disorders | Respiratory Tract Diseases | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | COVID 19 | Coronavirus | Metabolic Disease | Severe Acute Respiratory Syndrome Coronavirus 2 | Sars-CoV2 | Hormones | Hypoglycemic Agents | Incretins | Dipeptidyl-Peptidase IV Inhibitors and other conditionsIsrael
-
TakedaCompletedDiabetes MellitusRussian Federation
-
Assistance Publique - Hôpitaux de ParisCompleted
-
EMSNot yet recruitingType 2 Diabetes Mellitus
-
University of PisaCompletedType2 Diabetes MellitusItaly
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Unity Health TorontoCompletedHeart Failure | Diabetes Mellitus, Non-Insulin-DependentCanada
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, New Zealand, Spain, Japan, Finland, Germany, Greece, Romania, South Africa, Denmark, Colombia, Poland, United Kingdom, Mexico, Australia, Belgium, Ireland
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Australia, Canada, Denmark, Netherlands, Sweden
-
Dong Wha Pharmaceutical Co. Ltd.CompletedHealthy SubjectsKorea, Republic of
-
ikfe-CRO GmbHAstraZeneca; IKFE Institute for Clinical Research and DevelopmentUnknownDiabetes Mellitus, Type 2Germany
-
Universidad de GuanajuatoHospital Regional de Alta Especialidad del BajioCompletedInsulin Resistance | Prediabetic StateMexico
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
LG Life SciencesCompletedType 2 DM Patients With Moderate or Severe Renal ImpairmentKorea, Republic of
-
Beijing Chao Yang HospitalUnknownObesity | Type 2 Diabetes
-
Ministry of Public Health, ArgentinaAix Marseille Université; Instituto de Biología y Medicina Experimental, IBYME...Unknown
-
TakedaCompletedType 2 Diabetes MellitusJapan
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Germany